Please login to the form below

Not currently logged in
Email:
Password:

GSK comms head leaves to join AZ

GSK's vice-president for UK corporate affairs and EU communications is leaving to join AstraZeneca as global head of media relations

Neil McCrae, GlaxoSmithKline's (GSK) vice-president for UK corporate affairs and EU communications, is leaving to join AstraZeneca (AZ) as global head of media relations.

McCrae will leave at the beginning of 2008 after working for GSK for 11 years and will report to vice-president for group corporate communications, Caroline Hempstead. According to AZ, the position was created during the restructuring of the corporate affairs department at the company.

McCrae will be responsible for managing the group press office and building relationships with business and international media in London.

According to PR Week, McCrae's departure follows that of GSK's senior external communications manager, David Daley, who left to join The Health Protection Agency in the middle of November. Daley managed a team of five-strong team led by head of external communications Kate Hewer, who returned from maternity leave.

GSK has warned of job losses and has initiated cost-cutting measures to counter the falling sales experienced by its flagship diabetes drug, Avandia, as a result of cardiac safety warnings published in a US medical journal.

This week, GSK announced it would be shedding jobs from its US operations centre and a manufacturing site in North Carolina.

30th November 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell - Cake

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics